Takeda Bolsters its CNS Pipeline with Envoy Therapeutics Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 11 (Table of Contents)
Published: 22 Nov-2012
DOI: 10.3833/pdr.v2012.i11.1838 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Takeda Pharmaceutical has agreed to acquire Envoy Therapeutics for a total consideration of up to US$140 M, including upfront and preclinical milestone payments...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS